Article
PET in women with high risk for breast or ovarian cancer.
The Lancet. Oncology - 1 Sept 2010
Even-Sapir Einat, Inbar Moshe
Abstract excerpt
Data on the use of PET in women with genetic or familial high-risk for breast or ovarian cancer are scarce. Open issues include the complementary use of dedicated breast-PET scanners in patients at high-risk for breast cancer, the relation between pathological characteristics of cancer diagnosed in BRCA carriers and (18)F-fluorodeoxyglucose ((18)F-FDG)-avidity, and the predictive value of PET in patients at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
